Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Abscint Nv/sa

Clinical trials sponsored by Abscint Nv/sa, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New scan could spot cancer marker better than current tests Results expected Sep 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New scan could spot cancer marker better than current tests

Diagnosis Recruiting now

This study tests a new type of PET/CT scan that uses a radioactive tracer called 68Ga-ABS011 to detect HER2, a protein found on some cancer cells. The goal is to see if this scan can more accurately determine HER2 status in people with metastatic breast cancer or other solid tumo…

Phase 2 • Sponsor: Abscint NV/SA • Aim: Diagnosis

Last updated Jun 27, 2026 13:01 UTC